Several other brokerages also recently issued reports on ACHC. BMO Capital Markets lifted their price objective on Acadia Healthcare from $33.00 to $36.00 and gave the company a market perform rating in a research report on Wednesday, May 1st. Zacks Investment Research upgraded Acadia Healthcare from a sell rating to a hold rating in a research report on Thursday, January 24th. Mizuho set a $30.00 target price on Acadia Healthcare and gave the company a hold rating in a research note on Friday, January 25th. ValuEngine raised Acadia Healthcare from a strong sell rating to a sell rating in a research note on Wednesday, April 24th. Finally, Citigroup lowered their target price on Acadia Healthcare from $43.00 to $38.00 and set a buy rating for the company in a research note on Monday, March 4th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus price target of $36.80.
Shares of ACHC opened at $32.71 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 1.55. Acadia Healthcare has a 52-week low of $24.27 and a 52-week high of $45.35. The firm has a market capitalization of $2.89 billion, a price-to-earnings ratio of 14.60, a price-to-earnings-growth ratio of 1.78 and a beta of 0.70.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Ellington Management Group LLC increased its stake in shares of Acadia Healthcare by 0.7% in the 1st quarter. Ellington Management Group LLC now owns 44,236 shares of the company’s stock valued at $1,297,000 after buying an additional 309 shares during the period. Private Capital Group LLC grew its stake in shares of Acadia Healthcare by 67.3% during the first quarter. Private Capital Group LLC now owns 865 shares of the company’s stock worth $25,000 after purchasing an additional 348 shares during the period. SG Americas Securities LLC grew its stake in shares of Acadia Healthcare by 4.3% during the first quarter. SG Americas Securities LLC now owns 8,983 shares of the company’s stock worth $263,000 after purchasing an additional 368 shares during the period. Xact Kapitalforvaltning AB grew its stake in shares of Acadia Healthcare by 2.8% during the fourth quarter. Xact Kapitalforvaltning AB now owns 14,574 shares of the company’s stock worth $375,000 after purchasing an additional 400 shares during the period. Finally, BB&T Corp grew its stake in shares of Acadia Healthcare by 0.9% during the fourth quarter. BB&T Corp now owns 53,635 shares of the company’s stock worth $1,379,000 after purchasing an additional 455 shares during the period.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
Featured Article: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.